India donates vaccines to neighboring countries ahead of Chinese Communist Party’s slow pace and anger

A health worker shows a vial of Covishield (AstraZeneca-Oxford’s vaccine against the Chinese Communist virus) at Patan Hospital near Kathmandu, Nepal, Jan. 27, 2021.

India has been too finicky in the past, which has led the Chinese Communist Party to favor the Chinese Communist Party through the “One Belt, One Road” in South Asian countries with a big spill of money to aid infrastructure. The Modi government has recently shouted the policy of “neighboring countries first”, taking advantage of the Chinese Communist Party’s virus Epidemic to build an anti-epidemic cooperation platform, and after the two vaccines were approved and mass-produced, they were donated to neighboring countries ahead of the Chinese Communist Party. The Communist Party of China (CPC) was infuriated by the doubts about the transparency of the vaccines and even wrote an article criticizing Bangladesh for rejecting the Chinese vaccines and blaming it on India.

The Central News Agency reported that the government of Nepal’s Prime Minister K.P. Sharma Oli, who is considered to be pro-China, rejected the Chinese Communist Party’s initiative to provide the vaccine due to safety concerns and turned to India for assistance. The Covishield vaccine, developed by the University of Oxford and AstraZeneca and manufactured by the Serum Institute of India, was administered to all health care workers from January 27.

Oli publicly expressed his gratitude to India for donating the vaccine, and Nepal’s Minister of Health and Population Hridayesh Tripathi said that the Indian government’s donation of the vaccine is a goodwill gesture and a demonstration of its people-oriented spirit, as the people are the biggest victims of the Chinese Communist virus (COVID-19, Wuhan pneumonia) outbreak.

Bangladesh, which has received substantial investment from the Chinese Communist Party in recent years, was to be given 110,000 doses of vaccine by China, but after Bangladesh refused to pay for the vaccine’s research and development, China cancelled its donation plan, but India immediately accepted Bangladesh’s request and gave Bangladesh 2 million doses of vaccine for free.

In the past, the Modi government’s promotion of the new citizenship law claimed to stop illegal Muslim immigration from Bangladesh, which led to Bangladesh’s discontent and drifting away from India, but this Time the situation has changed due to India’s kindness.

The Chinese Communist Party has been trying to extend its influence into Bhutan, and India has given 150,000 doses of vaccines to Bhutan to strengthen bilateral ties.

Of the countries in South Asia and the Indian Ocean region, only Pakistan, a “hard-core ally” of the Chinese Communist Party, seems to be willing to accept vaccine donations from the Chinese Communist Party.

The Serum Institute of India is the world’s largest vaccine manufacturer, and with the capacity of other Indian pharmaceutical companies, the Indian government intends to provide another 12 to 20 million doses of vaccines to neighboring countries in the near future, allowing Modi to proudly say on several international occasions that Indian vaccines will soon be sent to countries around the world to save more lives.

By quickly donating vaccines, India has successfully won a diplomatic battle to weaken the Chinese Communist Party’s influence in the Indian Ocean region, leading the Chinese Communist Party’s Global Times to write an article criticizing India for interfering in the Chinese Communist Party’s clinical trials of vaccines with Bangladesh, causing a delay in the clinical trials of vaccines at Sinovac Biotech in Bangladesh from July to October.

Indian media reported that Sinovac Biotech asked the Bangladeshi government to cover the cost of local clinical trials of Sinovac’s vaccine, causing Bangladesh to turn to India for the vaccine, which led the Global Times to cite Chinese experts as criticizing the Indian media for “smearing” the case. But the Global Times article also admits that Kexing could not afford the cost of clinical trials in Bangladesh, so it asked Bangladesh to cooperate and share the cost.

“According to an article on the India News Network, the Global Times seems to have ignored the fact that some countries have reacted negatively and coldly to vaccines developed and produced in China because of the opaque experimental methods used by these Chinese vaccine companies; even in some Chinese provinces, a A large part of the population refuses to administer Chinese vaccines because they fear that the lack of transparency in both production and experimentation could endanger their health.